scholarly journals Canadian Society for Vascular Surgery consensus statement on endovascular aneurysm repair

2005 ◽  
Vol 172 (7) ◽  
pp. 867-868 ◽  
Author(s):  
T. F. Lindsay
2016 ◽  
Vol 64 (2) ◽  
pp. 338-347 ◽  
Author(s):  
Salvatore T. Scali ◽  
Sara J. Runge ◽  
Robert J. Feezor ◽  
Kristina A. Giles ◽  
Javairiah Fatima ◽  
...  

2008 ◽  
Vol 90 (2) ◽  
pp. 96-99 ◽  
Author(s):  
Toby Richards ◽  
Keith Jones

INTRODUCTION In the UK, surgical training includes all aspects of general surgery. Vascular surgery is not an independent specialty. We wished to assess the views of vascular trainees in UK on the future of vascular surgery and training. MATERIALS AND METHODS Trainees were surveyed in 2003, 2004 (after introduction of the European Working Time Directive) and 2005, concentrating on four areas – future practise of vascular surgery, role of endovascular training, vascular specialisation and future training. RESULTS The majority of trainees want to practise vascular surgery alone. In 2003, 80% thought training should include endovascular techniques. By 2005, all trainees regarded training as mandatory as endovascular techniques would represent a significant part of their future work. Opinion changed on training; from 4 years general then 2 years vascular surgery (qualification in general surgery) to 2 years general and 4 years vascular surgery (specialist qualification in vascular surgery; P < 0.0001). Opinion also changed, that vascular surgery should spilt from general surgery to form its own speciality (P < 0.0007). CONCLUSIONS Trainees now regard training in endovascular techniques and endovascular aneurysm repair as mandatory. The majority wish to specialise from general surgery and achieve a separate qualification in vascular surgery.


2010 ◽  
Vol 24 (8) ◽  
pp. 1075-1081 ◽  
Author(s):  
Dusadee Sarangarm ◽  
Jordan Knepper ◽  
John Marek ◽  
Kristen L. Biggs ◽  
Diane Robertson ◽  
...  

2021 ◽  
Vol 27 ◽  
pp. 107602962110447
Author(s):  
Alia Uzra Kazimi ◽  
Christian Friedrich Weber ◽  
Michael Keese ◽  
Wolfgang Miesbach

Background An antiplatelet therapy with acetylsalicylic acid (ASA) is prescribed in the prevention of cardiovascular events, but around 24% of ASA takers are resistant to the treatment. Aim In this prospective, observational cohort study, we aimed to identify the prevalence and risk factors of ASA nonresponse in patients who underwent vascular surgery. Methods The study was conducted in the University hospital in Frankfurt am Main. In total, 70 patients were pre-treated with 100 mg of ASA per day and underwent either elective carotid thromboendarterectomy, femoral thromboendarterectomy or endovascular aneurysm repair of the abdominal aorta. The platelet function was measured on the first preoperative and the second or fourth postoperative day with the multiple electrode aggregometry by in-vitro stimulation with arachidonic acid (ASPItest) and thrombin receptor activating peptide 6 (TRAPtest). The primary end point was the in-vitro induced platelet aggregation in the ASPItest. If the ASPItest amounted ≥400 AU × min, the patients were categorized as ASA nonresponders. Results The total prevalence of ASA nonresponse in our study was 20% preoperatively and 35.7% postoperatively (p = 0.005). As significant predictors for ASA nonresponse, we demonstrated the area under the aggregation curve in the TRAPtest preoperatively (p = 0.04) and postoperatively (p = 0.02), and the two comorbidities arterial hypertension ( P < .001; rho 0.44) and diabetes mellitus (p = 0.04; rho 0.39), which are already well known to be associated with ASA nonresponse. Conclusion In conclusion, data of the study indicate a high incidence of perioperative, laboratory ASA nonresponse in patients undergoing vascular surgery.


Sign in / Sign up

Export Citation Format

Share Document